Venus Remedies gains on marketing nod from Venezuela

Apr 04 2014, 14:12 IST
Comments 0
The scrip was trading 13.19% higher at Rs 299 on the BSE at 1.00 pm IST.v (Reuters) The scrip was trading 13.19% higher at Rs 299 on the BSE at 1.00 pm IST.v (Reuters)
SummaryShares of Venus Remedies gained more than 17% in intraday on Friday after the pharma company in an exchange release...

Shares of Venus Remedies gained more than 17% in intraday on Friday after the pharma company in an exchange release announced that it has recieved marketing nod from Venezuela for the injectible anti-biotic meropenem.

"Company is planning to launch meropenem in Venezuela in next couple of months. The $-10 billion meropenem market in Venezuela offers a great opportunity to us and we are aiming to capture a sizeable market in the first year of the launch," the company said.

The scrip was trading 13.19% higher at Rs 299 on the BSE at 1.00 pm IST.

Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...